Next-generation healthcare company Prime Medicine (NASDAQ: PRME) was exactly what the doctor ordered for ailing portfolios on the first trading day of the week. On a company update and news of collaboration with a top healthcare business, investors piled into the gene-editing spe… nasdaq.com/articles/why-prime-medicine-stock-soared-nearly-12-higher-monday” target=”_blank” rel=”noopener”> » …
Why Prime Medicine Stock Soared Nearly 12% Higher on Monday
Subscribe Today
GET EXCLUSIVE FULL ACCESS TO PREMIUM CONTENT
SUPPORT NONPROFIT JOURNALISM
EXPERT ANALYSIS OF AND EMERGING TRENDS IN CHILD WELFARE AND JUVENILE JUSTICE
TOPICAL VIDEO WEBINARS
Get unlimited access to our EXCLUSIVE Content and our archive of subscriber stories.